Oric Pharmaceuticals Share Price: ORIC (Oric Pharmaceuticals) Stock Price Today & Updates | INDmoney

Question 1

What is Oric Pharmaceuticals share price today?

Accepted Answer

Oric Pharmaceuticals (ORIC) share price today is {{live_price}}.

Question 2

Can Indians buy Oric Pharmaceuticals shares?

Accepted Answer

Yes, Indians can invest in the Oric Pharmaceuticals (ORIC) from India.

With INDmoney, you can buy Oric Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Oric Pharmaceuticals at zero transaction cost.

Question 3

How can I buy Oric Pharmaceuticals shares from India?

Accepted Answer

It is very easy to buy Oric Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Oric Pharmaceuticals be purchased?

Accepted Answer

Yes, you can buy fractional shares of Oric Pharmaceuticals with INDmoney app.

Question 5

What are the documents required to start investing in Oric Pharmaceuticals stocks?

Accepted Answer

To start investing in Oric Pharmaceuticals, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Oric Pharmaceuticals

Accepted Answer

Today’s highest price of Oric Pharmaceuticals (ORIC) is {{1_rba_end}}.

Today’s lowest price of Oric Pharmaceuticals (ORIC) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Oric Pharmaceuticals

Accepted Answer

Today's market capitalisation of Oric Pharmaceuticals ORIC is 645.5M

Question 8

What is the 52 Week High and Low Range of Oric Pharmaceuticals

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Oric Pharmaceuticals is down from its 52 Week High?

Accepted Answer

Oric Pharmaceuticals (ORIC) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Oric Pharmaceuticals is up from its 52 Week low?

Accepted Answer

Oric Pharmaceuticals (ORIC) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Oric Pharmaceuticals?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Oric Pharmaceuticals

Accepted Answer

Dr. Richard A. Heyman Ph.D. is the current Chief Executive Officer (CEO) of Oric Pharmaceuticals.

Period	Oric Pharmaceuticals	Sector (Health Care)	Index (Russel 2000)
3 Months	-11.6%	3.6%	0.0%
6 Months	8.37%	10.2%	0.0%
1 Year	73.08%	19.6%	0.0%
3 Years	-37.46%	16.8%	-23.0%

Market Capitalization	645.5M
Book Value	$4.47
Earnings Per Share (EPS)	-1.76
Wall Street Target Price	18.75

Profit Margin	0.0%
Operating Margin TTM	0.0%

Return On Assets TTM	-25.2%
Return On Equity TTM	-38.79%

Revenue TTM	0.0
Revenue Per Share TTM	0.0
Quarterly Revenue Growth YOY	0.0%
Gross Profit TTM	0.0
EBITDA	-124.1M
Diluted Eps TTM	-1.76
Quarterly Earnings Growth YOY	0.0

Oric Pharmaceuticals (ORIC)

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Technicals Summary

Peers

Vs ALNY

Vs VRTX

Institutional Holdings

Company Information

Discover More

FAQs

EPS Estimate Current Year	-1.81
EPS Estimate Next Year	-2.09
EPS Estimate Current Quarter	-0.41
EPS Estimate Next Quarter	-0.43

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Oric Pharmaceuticals	-11.93%	8.37%	73.08%	-37.46%	-63.33%
Regeneron Pharmaceuticals, Inc.	-9.28%	10.06%	24.53%	74.0%	232.45%
Novo Nordisk A/s	-4.54%	-5.72%	21.59%	126.2%	349.01%
Alnylam Pharmaceuticals, Inc.	8.87%	102.98%	82.67%	44.83%	241.09%
Vertex Pharmaceuticals Incorporated	5.0%	20.77%	31.37%	158.16%	163.17%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Oric Pharmaceuticals	NA	NA	NA	-1.81	-0.39	-0.25	NA	4.47
Regeneron Pharmaceuticals, Inc.	26.41	26.41	1.37	44.9	0.17	0.08	NA	261.41
Novo Nordisk A/s	40.21	40.21	1.81	3.36	0.89	0.23	0.01	25.24
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-2.42	-15.01	0.02	NA	-0.02
Vertex Pharmaceuticals Incorporated	32.84	NA	0.59	0.18	-0.03	0.13	NA	57.26

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Oric Pharmaceuticals	Buy	$645.5M	-63.33%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$110.0B	232.45%	26.41	32.04%
Novo Nordisk A/s	Buy	$529.8B	349.01%	40.21	34.84%
Alnylam Pharmaceuticals, Inc.	Buy	$38.1B	241.09%	NA	-3.11%
Vertex Pharmaceuticals Incorporated	Buy	$128.7B	163.17%	32.84	-4.74%

Organization	Oric Pharmaceuticals
Employees	107
CEO	Dr. Richard A. Heyman Ph.D.
Industry	Health Technology